Targeted Toxicities: Protocols for Monitoring the Adverse Events of Targeted Therapies Used in the Treatment of Non-Small Cell Lung Cancer

Targeted Toxicities: Protocols for Monitoring the Adverse Events of Targeted Therapies Used in the Treatment of Non-Small Cell Lung Cancer

Targeted therapies have revolutionized the treatment for many patients with non-small cell lung cancer (NSCLC). Multiple new oral targeted therapies have been approved in the last decade; however, their overall efficacy may be reduced by poor adherence, treatment interruptions, or dose reductions du...

Full description

Bibliographic Details
Main Authors: Jacobi B. Hines, Benjamin Bowar, Emma Levine, Alessandra Esposito, Marina C. Garassino, Christine M. Bestvina
Format: Article
Language:English
Published: MDPI AG 2023-05-01
Series:International Journal of Molecular Sciences
Subjects:
non-small cell lung cancer
molecular targeted therapies
adverse drug events
toxicity
pharmacovigilance
Online Access:https://www.mdpi.com/1422-0067/24/11/9429

Internet

https://www.mdpi.com/1422-0067/24/11/9429

Similar Items